Products & Service
CDMO
Taienkang’s parent company has three R&D bases, which are respectively Shandong Bubble Kisen Biological Technology Co., Ltd., Bochuangyuan (BCY) Pharm Co., Ltd., and Sichuan Checo Pharmaceutical Technology Co., Ltd. It has a 66,745 square meters production base for APIs and intermediate in Yuechi County, Sichuan Province, strictly in compliance with GMP standard. The R&D team is composed of experienced Ph.D. and master's degree researchers who have worked for pharmaceutical product R&D and drug registration in leading pharmaceutical companies. They are also equipped with extensive practical experience and familiar with drug molecular structure and process route design. According to clients’ needs, they can efficiently conduct laboratory research and scale up for commercial production, as well as timely completing contract R&D and production projects for delivery.
Process Development
Three R&D bases with strong and experienced teams. Process optimization and production cost reduction.
Production
The factory plans to build 6 production workshops with 500L-5000L multifunctional reactors that comply with GMP standards and can meet clients’ needs for pilot/validation/commercial production.
Quality Studies
The company has a professional quality management team and state-of-the-art equipment and instruments, providing clients with quality study and stability study services for APIs and intermediates to ensure they meet application requirements. These include analytical method development/optimization, analytical method validation/transfer, specification research, stability studies, product release testing etc.
Regulatory Affair Support
The company has a professional, efficient, and experienced regulatory affairs team that can provides clients with CMC/DMF documents for domestic and international drug registration.